In this study, we reported 145 patients with initially unresectable HCC who received HAIC plus PD-1 inhibitors and TKIs with CR of 6.2%, ORR of 57.2%, DCR of 89.7%, and successful conversion rate of 18.6%. Here, PDCD1 is linked to hepatocellular carcinoma.